Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 104

    1.

    Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration.

    Kozak I, Cheng L, Cochran DE, Freeman WR.

    Br J Ophthalmol. 2006 Sep;90(9):1152-6. Epub 2006 Jun 14.PMID: 16774958 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

    Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES.

    Arch Ophthalmol. 1999 Sep;117(9):1161-73. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496388 [PubMed - indexed for MEDLINE]Related articles

    3.

    Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

    Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.

    Arch Ophthalmol. 1999 Sep;117(9):1177-87. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496389 [PubMed - indexed for MEDLINE]Related articles

    6.

    Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.

    Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC; Visudyne in Minimally Classic Choroidal Neovascularization Study Group.

    Arch Ophthalmol. 2005 Apr;123(4):448-57.PMID: 15824216 [PubMed - indexed for MEDLINE]Related articles

    7.

    Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.

    Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.

    Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1241-6. Epub 2005 Jul 12.PMID: 16010552 [PubMed - indexed for MEDLINE]Related articles

    8.

    Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

    Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

    Arch Ophthalmol. 2001 Feb;119(2):198-207.PMID: 11176980 [PubMed - indexed for MEDLINE]Related articles

    9.

    Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

    Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

    Arch Ophthalmol. 2002 Nov;120(11):1443-54.PMID: 12427056 [PubMed - indexed for MEDLINE]Related articles

    10.

    Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Ophthalmology. 2006 Jan;113(1):14-22. Epub 2005 Dec 19.PMID: 16360209 [PubMed - indexed for MEDLINE]Related articles

    11.

    Short-term reaction of choroidal neovascularization and choriocapillaris to photodynamic therapy in age-related macular degeneration.

    Eter N, Vogel A, Inhetvin-Hutter C, Spitznas M.

    Eur J Ophthalmol. 2003 Oct;13(8):687-92.PMID: 14620172 [PubMed - indexed for MEDLINE]Related articles

    12.

    Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

    Blumenkranz MS, Bressler NM, Bressler SB, Donati G, Fish GE, Haynes LA, Lewis H, Miller JW, Monés JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Schachat AP, Schmidt-Erfurth U, Sickenburg M, Singerman LJ, Slakter JS, Strong A, Vannier S; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

    Arch Ophthalmol. 2002 Oct;120(10):1307-14.PMID: 12365909 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Visudyne photodynamic therapy and feeder vessel occlusion: rationale of a synergistic association and clinical options]

    Sickenberg M, Ballini JP, van den Bergh H.

    J Fr Ophtalmol. 2004 Jan;27(1):93-102. French. PMID: 14968086 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Photodynamic therapy in age-related macular degeneration--results of one year observation]

    Wykrota H, Gierek-Łapińska A.

    Klin Oczna. 2002;104(3-4):239-43. Polish. PMID: 12608309 [PubMed - indexed for MEDLINE]Related articles

    17.

    Photodynamic therapy with delayed light application for the treatment of bilateral subfoveal choroidal neovascularization in age-related macular degeneration.

    Karacorlu M, Karacorlu S, Ozdemir H.

    Jpn J Ophthalmol. 2003 Nov-Dec;47(6):595-8.PMID: 14636851 [PubMed - indexed for MEDLINE]Related articles

    18.

    Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.

    Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group.

    Retina. 2004 Feb;24(1):1-12.PMID: 15076937 [PubMed - indexed for MEDLINE]Related articles

    19.

    Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization.

    Rosenblatt BJ, Shah GK, Blinder K.

    Retina. 2005 Jan;25(1):33-7.PMID: 15655438 [PubMed - indexed for MEDLINE]Related articles

    20.

    Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy.

    Gelisken F, Lafaut BA, Inhoffen W, Voelker M, Grisanti S, Bartz-Schmidt KU.

    Br J Ophthalmol. 2004 Feb;88(2):207-11.PMID: 14736776 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data